Home › Clinical Tools › VTE-BLEED

🩸 VTE-BLEED Score

UseWhen to use: after acute phase, deciding intensity/monitoring of extended AC.

Loading calculator…

Strata<2 lower bleed band; ≥2 intensify monitoring and revisit net benefit.

LimitsWhen not to use: alone for acute inpatient bleed risk. · Pitfall: ignoring falls/drugs/procedure plans. · Pair with recurrence scores (HERDOO2/DASH).

SourceKlok FA et al. VTE-BLEED

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Score + version; reference only — not a substitute for care · no HIS write

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

≥2 high band.

When to use

When to use: after acute phase, deciding intensity/monitoring of extended AC.

How it works

Cancer +2; male+SBP≥140 +1; anemia +1.5; prior bleed +1.5; age≥60 +1.5; CrCl/eGFR<60 +1.5.

Key points

  • ≥2 high band.
  • Stable AC context.
  • Next: HERDOO2 / dose review.

References

  • Klok FA et al. VTE-BLEED

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

Active cancerNo (0)
Male with uncontrolled HTN (SBP ≥140 mmHg)No (0)
Anemia (Hb <13 g/dL men or <12 g/dL women)No (0)
History of bleedingNo (0)
Age ≥60 yearsNo (0)
Renal dysfunction (CrCl/eGFR <60 mL/min)No (0)

→VTE-BLEED0

  • Cue:<2 — low bleeding-risk band on stable AC
Active cancerYes (+2)
Male with uncontrolled HTN (SBP ≥140 mmHg)Yes (+1)
Anemia (Hb <13 g/dL men or <12 g/dL women)Yes (+1.5)
History of bleedingYes (+1.5)
Age ≥60 yearsYes (+1.5)
Renal dysfunction (CrCl/eGFR <60 mL/min)Yes (+1.5)

→VTE-BLEED9

  • Cue:≥2 — high bleeding-risk band; intensify monitoring / address modifiable factors
Verification & sources · governance
FAQ

Frequently asked questions

Does VTE-BLEED Score upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is VTE-BLEED Score calculated in practice? Can you show a worked example?
Inputs: Active cancer No (0), Male with uncontrolled HTN (SBP ≥140 mmHg) No (0), Anemia (Hb <13 g/dL men or <12 g/dL women) No (0), History of bleeding No (0), Age ≥60 years No (0), Renal dysfunction (CrCl/eGFR <60 mL/min) No (0) → Result: VTE-BLEED 0(Cue: <2 — low bleeding-risk band on stable AC) Inputs: Active cancer Yes (+2), Male with uncontrolled HTN (SBP ≥140 mmHg) Yes (+1), Anemia (Hb <13 g/dL men or <12 g/dL women) Yes (+1.5), History of bleeding Yes (+1.5), Age ≥60 years Yes (+1.5), Renal dysfunction (CrCl/eGFR <60 mL/min) Yes (+1.5) → Result: VTE-BLEED 9(Cue: ≥2 — high bleeding-risk band; intensify monitoring / address modifiable factors)
Related tools